
The stock closed at ₹150.08 on the NSE on Friday, up 2.35%, but is down nearly 19% from its 52-week high of ₹254.50

HCG reports Q4 PAT down 70% to ₹2.17 crore, while revenue rises 11% to ₹650.29 crore amid strategic growth initiatives.

Sales grew by 27.53% during the year, driven by rising demand across premium spirits, wines and emerging alcobev categories